Oligosol® Sélénium
Oligosol® Sélénium, licence 02244237: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Labcatal S.A.
- NPN or DIN-HM
- 02244237
- Status
- Active licence
- Licence date
- 28 May 2008
- Revision date
- Not provided
- Form
- Aérosol
- Route of administration
- Orale
- Application type
- DIN de transition
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Eau, Acide benzoïque
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 4.0 Année(s) | 2.0 mL | minimum: 1.0 Tous les jours ; maximum: 2.0 Tous les jours |
| Enfants | minimum: 2.0 Année(s) ; maximum: 4.0 Année(s) | 1.0 mL | minimum: 1.0 Tous les jours ; maximum: 2.0 Tous les jours |
| Adultes | Not specified | 2.0 mL | minimum: 1.0 Tous les jours ; maximum: 2.0 Tous les jours |
| Enfants | minimum: 6.0 Mois ; maximum: 24.0 Mois | 1.0 mL | minimum: 1.0 Tous les jours ; maximum: 2.0 Tous les jours |
Uses authorised in Canada
Traditionnellement utilisé en oligothérapie pour neutraliser les radicaux libres et protéger contre le vieillissement, la dégénération cellulaire, et les affections musculaires et cutanées.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 02244237
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.